JPS4884082A - - Google Patents

Info

Publication number
JPS4884082A
JPS4884082A JP48010381A JP1038173A JPS4884082A JP S4884082 A JPS4884082 A JP S4884082A JP 48010381 A JP48010381 A JP 48010381A JP 1038173 A JP1038173 A JP 1038173A JP S4884082 A JPS4884082 A JP S4884082A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP48010381A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4884082A publication Critical patent/JPS4884082A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4853—Kallikrein (3.4.21.34 or 3.4.21.35)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/02—Crystallisation from solutions
    • B01D9/04—Crystallisation from solutions concentrating solutions by removing frozen solvent therefrom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP48010381A 1972-02-01 1973-01-26 Pending JPS4884082A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2204598A DE2204598A1 (de) 1972-02-01 1972-02-01 Anwendung eines verfahrens zur gefrierkonzentrierung von waessrigen loesungen von arzneimitteln

Publications (1)

Publication Number Publication Date
JPS4884082A true JPS4884082A (ja) 1973-11-08

Family

ID=5834656

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48010381A Pending JPS4884082A (ja) 1972-02-01 1973-01-26

Country Status (9)

Country Link
US (1) US3897409A (ja)
JP (1) JPS4884082A (ja)
AT (1) AT323319B (ja)
BE (1) BE794743A (ja)
DE (1) DE2204598A1 (ja)
FR (1) FR2170135B1 (ja)
GB (1) GB1410541A (ja)
NL (1) NL7301244A (ja)
PL (1) PL89089B1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9527540B2 (en) 2011-07-15 2016-12-27 Revolights, Inc. Bicycle lighting systems and methods
US8337060B1 (en) 2011-07-15 2012-12-25 John Kent Frankovich Bicycle lighting systems and methods
USD685509S1 (en) 2011-10-12 2013-07-02 Revolights, Inc. Bicycle lighting system
US9227559B2 (en) 2012-12-31 2016-01-05 Revolights, Inc. Vehicle lighting control system and method
US8956542B1 (en) * 2013-07-30 2015-02-17 Showa Freezing Plant Co., Ltd. Method for processing radioactively-contaminated water
JP6529131B2 (ja) * 2013-08-29 2019-06-12 株式会社明治 凍結濃縮法による濃縮製品の製造方法
US10393365B2 (en) 2017-04-05 2019-08-27 Revolights, Inc. Wheelchair lighting systems and methods
CN111646923B (zh) * 2020-06-18 2022-11-15 山西省科技资源与大型仪器开放共享中心 一种冷冻浓缩提纯羟基乙腈的方法

Also Published As

Publication number Publication date
GB1410541A (en) 1975-10-15
NL7301244A (ja) 1973-08-03
BE794743A (fr) 1973-07-30
DE2204598A1 (de) 1973-08-09
AT323319B (de) 1975-07-10
FR2170135A1 (ja) 1973-09-14
US3897409A (en) 1975-07-29
FR2170135B1 (ja) 1977-02-04
PL89089B1 (ja) 1976-10-30

Similar Documents

Publication Publication Date Title
JPS4983767A (ja)
FR2204596A2 (ja)
FR2200448A1 (ja)
JPS4915969A (ja)
FR2170135A1 (ja)
CS158170B2 (ja)
JPS5538973B2 (ja)
JPS5316628Y2 (ja)
JPS49100276A (ja)
JPS4916331A (ja)
JPS4919569A (ja)
JPS4961680U (ja)
CS153936B1 (ja)
CS151840B1 (ja)
CS157307B1 (ja)
CS155028B1 (ja)
CS156805B1 (ja)
CS156971B1 (ja)
CH571105B5 (ja)
CH563109A5 (ja)
CH575128A5 (ja)
CH589058A5 (ja)
CH566258A5 (ja)
CH566534A5 (ja)
CH576696A5 (ja)